SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Micromet, Inc. – ‘10-K’ for 12/31/03 – EX-32

On:  Monday, 3/29/04, at 4:12pm ET   ·   For:  12/31/03   ·   Accession #:  936392-4-303   ·   File #:  0-50440

Previous ‘10-K’:  None   ·   Next:  ‘10-K’ on 3/15/05 for 12/31/04   ·   Latest:  ‘10-K’ on 3/2/12 for 12/31/11

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/29/04  Micromet, Inc.                    10-K       12/31/03    7:931K                                   Bowne - BSD/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Form 10-K Year Ended 12-31-03                       HTML    840K 
 2: EX-10.08    Material Contract                                     12     52K 
 3: EX-21.01    Subsidiaries of the Registrant                         1      4K 
 4: EX-23.01    Consent of Experts or Counsel                          1      6K 
 5: EX-31.1     Certification per Sarbanes-Oxley Act (Section 302)     2±     9K 
 6: EX-31.2     Certification per Sarbanes-Oxley Act (Section 302)     2±     9K 
 7: EX-32       Certification per Sarbanes-Oxley Act (Section 906)     1      7K 


EX-32   —   Certification per Sarbanes-Oxley Act (Section 906)

EX-32TOCTopPreviousNextBottomJust 1st
 

Exhibit 32 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of CancerVax Corporation (the "Company") on Form 10-K for the period ended December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, David F. Hale, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: 1. The Report fully complies with the requirements of Section 13(a) or 15(d), of the Securities Exchange Act of 1934; and 2. That information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: March 29, 2004 /s/ David F. Hale --------------------------------------- David F. Hale Chief Executive Officer In connection with the Annual Report of CancerVax Corporation (the "Company") on Form 10-K for the period ended December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William R. LaRue, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: 1. The Report fully complies with the requirements of Section 13(a) or 15(d), of the Securities Exchange Act of 1934; and 2. That information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: March 29, 2004 /s/ William R. LaRue --------------------------------------- William R. LaRue Chief Financial Officer

Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/29/04None on these Dates
For Period End:12/31/03
 List all Filings 
Top
Filing Submission 0000936392-04-000303   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 10:23:09.1am ET